Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 11:57 PM
Ignite Modification Date: 2025-12-24 @ 11:57 PM
NCT ID: NCT00145951
Eligibility Criteria: Inclusion criteria include: * (1) age 14-18 years and * (2) one risk factor for developing depression in the next two years: sub-clinical depressed mood (not meeting criteria of major depression), * a family history of depression in a parent or sibling, or past personal history of depression or personal perception of risk depression and desire to participate Exclusion Criteria: * criteria include meeting criteria or undergoing active treatment for major depression (5 or more symptoms nearly every day with functional impairment, minor depression), * bipolar disorder, * panic disorder, * conduct disorder, * substance abuse or having suicidal ideation. * Active treatment for depression is defined as receiving anti-depressant medication or counseling within one year of remission of symptoms from the most recent episode. * Those who meet DSM-IV criteria for minor depression (3-4 symptoms) or who report significant functional impairment (very difficult or above on the Prime MD functional impairment scale) will be notified and offered a referral for an evaluation by a mental health specialist (and will be strongly encouraged to attend). * Those with 1-2 symptoms of depression will also be offered evaluation and treatment from a mental health specialist. In each case, the primary care physician will be notified and the parents (if under the age of 19).
Healthy Volunteers: True
Sex: ALL
Minimum Age: 14 Years
Maximum Age: 75 Years
Study: NCT00145951
Study Brief:
Protocol Section: NCT00145951